Canada and Gavi, the Vaccine Alliance
Gavi, the Vaccine Alliance is a global health partnership that provides immunizations to the world’s poorest people.
Established in 2000, Gavi works with private partners to provide new and underused vaccines to developing countries that cannot afford them.
Gavi supports vaccines that immunize children against pneumonia, diarrhea and meningitis, some of the world’s leading killers of children.
To date, Gavi has immunized more than 580 million children and saved an estimated 8 million lives. Yet, approximately 1.5 million children die from vaccine-preventable illness every year and 19 million infants are still not able to access life-saving vaccines.
Effective investment in global health
Recognizing immunization is one of the most cost effective investments in global health, Gavi’s work aligns with Canada’s focus on the health and rights of women and children.
Canada is a longstanding partner of Gavi and we have been a member of the Gavi Board since its inception.
Board seats are held by:
- recipient countries
- vaccine manufacturers
- civil society organizations
- research and technical institutions
- independent technical experts
- Gavi Alliance partners: UNICEF, the World Health Organization (WHO), the World Bank, and the Bill and Melinda Gates Foundation
Canada’s support for Gavi
To date, Canada has provided more than 1 billion in funding to Gavi. Our work with Gavi focuses on:
- reaching more vulnerable populations in Francophonie countries in Africa, which have some of the lowest immunization rates in the world
- supporting Gavi’s Advance Market Commitment (AMC), that will increase availability of the pneumococcal vaccine to reach 26 million children in more than 50 countries by 2020.
- investing in an adequate immunization supply that meets current needs and cold storage facilities to protect the vaccines
- supporting measles and rubella immunization campaigns.
Canada, as lead donor for the Multilateral Organization Performance Assessment Network (MOPAN) Review of Gavi, will be presenting the report in Geneva in Spring 2017.
As of 2015, with the help of Canada and other donors, Gavi has achieved the following results:
- preventing more than 8 million deaths through vaccines for pentavalent, pneumococcal, rotavirus, yellow fever, meningitis A, Japanese encephalitis, human papilloma virus, measles second dose and measles-rubella and rubella
- immunizing 580 million children
- immunizing 10 million children against polio with the inactivated polio vaccine
- providing 1 million girls with HPV vaccines
- strengthening the health systems of more than 60 countries
- lowering the cost to fully immunize a child with pentavalent, pneumococcal and rotavirus from US$ 35 in 2010 to US $20 in 2015.
- Date Modified: